Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,601 | -4,565 | -3,870 | -3,254 | -18,012 |
| Depreciation Amortization | 3 | 2 | 2 | N/A | 30 |
| Other Working Capital | 1,823 | 1,023 | 597 | 1,269 | -1,471 |
| Other Operating Activity | -3,800 | -4,102 | -1,869 | 179 | 637 |
| Operating Cash Flow | $-9,575 | $-7,643 | $-5,140 | $-1,806 | $-18,815 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 8,018 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $8,018 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,731 | 18,395 | 19,012 | 759 | 3,123 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -30 |
| Financing Cash Flow | $18,731 | $18,395 | $19,012 | $759 | $3,094 |
| Exchange Rate Effect | 725 | 763 | 1,050 | 82 | -147 |
| Beginning Cash Position | 15,535 | 15,141 | 15,734 | 16,081 | 24,233 |
| End Cash Position | 25,415 | 26,656 | 30,655 | 15,116 | 16,383 |
| Net Cash Flow | $9,881 | $11,515 | $14,921 | $-965 | $-7,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,575 | -7,643 | -5,140 | -1,806 | -18,815 |
| Free Cash Flow | -9,575 | -7,643 | -5,140 | -1,806 | -18,815 |